ABL1 and acute lymphoblastic leukemia: We started by testing two fluorescent syngeneic models of leukemia to study circulation kinetics, a BCR-ABL driven B cell ALL model and an MLL-AF9 driven AML model31–36, each paired with healthy recipients.